Thyroid disorders in adult patients with chronic renal failure
Article Sidebar
Main Article Content
Abstract
Introduction: hypothyroidism can be associated with chronic kidney failure and its symptoms can overlap.
Objectives: to determine the frequency and clinical characteristics of silent thyroid disorders in adult patients with chronic renal failure.
Methodology: we conducted an observational, correlational, prospective, multicenter study. We included adults’ men and women, with chronic kidney failure, who attended the National Hospital (Itauguá) and the Military Hospital (Asunción) during 2020. The subjects who gave their consent were invited to the determination of the serum thyroid profile. Subjects in predialytic and dialytic therapy were included. Known carriers of thyroid diseases were excluded. Demographic and clinical variables were measured. We applied descriptive and analytical statistics. The protocol was approved by the Ethics Committee of the Universidad Privada del Este.
Results: we included 103 women and 115 men, with a mean age of 58 and 57 years, respectively. Overweight was found in 52,4 % and obesity in 16,6 %. In 66 % of the cases the patients were in stage 5 of renal failure. Diabetic and hypertensive origin was the predominated etiology. Anemia was found in 90 %. Regarding the thyroid profile, 20,2 % were found in the normal range, 12,4 % in clinical hypothyroidism, 15,6 % in subclinical hypothyroidism, 20,2 % with euthyroid sick syndrome and 31,6 % with low T3 syndrome. A significant association was found between creatinine clearance and thyroid status.
Conclusion: 28 % had some degree of hypothyroidism. Thyroid function screening is recommended in patients with chronic renal failure.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Aguirre C, Castillo Rascón M, Haseitel M. Hipotiroidismo subclínico en pacientes con enfermedad renal crónica que concurren a centros de salud pública de la ciudad de Posadas, Misiones. Rev Argent Endocrinol Metab. 2017;54(3):130–5. doi: 10.1016/j.raem.2017.07.002
Rhee C. The interaction between thyroid and kidney disease: An overview of the evidence. Curr Opin Endocrinol Diabetes Obes. 2016;23(5):407–15. doi: 10.1097/MED. 0000000000000275
Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocrinol Metab. 2012;16(2):204. doi: 10.4103/2230-8210.93737
Biondi B, Cappola AR, Cooper DS. Subclinical Hypothyroidism. JAMA. 2019;322(2):153–60. doi: 10.1001/jama.2019.9052
Martínez L. Frecuencia de hiper e hipotiroidismo subclínicos en pacientes derivados al Instituto de Investigaciones en Ciencias de la Salud. Mem Inst Investig Cienc Salud. 2008;6(2):25–31. Disponible en: http://scielo.iics.una.py/pdf/iics/v6n2/v6n2a05.pdf
Afsar B, Yilmaz MI, Siriopol D, Unal HU, Saglam M, Karaman M, et al. Thyroid function and cardiovascular events in chronic kidney disease patients. J Nephrol. 2017;30(2):235–42. doi: 10.1007/s40620-016-0300-y
Rhee C, Kalantar-Zadeh K, Streja E, Carrero J, Ma J, Lu J, et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transplant. 2015;30(2):282–7. doi: 10.1093/ndt/gfu303
Chávez Valencia V, Mejía Rodríguez O, Viveros Sandoval ME, Abraham Bermúdez J, Gutiérrez Castellanos S, Orizaga de la Cruz C, et al. Prevalencia del síndrome complejo de malnutrición e inflamación y su correlación con las hormonas tiroideas en pacientes en hemodiálisis crónica. Nefrología. 2018;38(1):57–63. doi: 10.1016/j.nefro.2017.07.001
Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: Who to treat and how. Drugs. 2012;72(1):17–33. doi: 10.2165/11598070-000000000-00000
Targher G, Chonchol M, Zoppini G, Salvagno G, Pichiri I, Franchini M, et al. Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis. Clin Chem Lab Med. 2009;47(11):1367–71. doi: 10.1515/CCLM.2009.304
Xu H, Brusselaers N, Lindholm B, Zoccali C, Carrero JJ. Thyroid function test derangements and mortality in dialysis patients: A systematic review and meta-analysis. Am J Kidney Dis. 2016;68(6):923–32. doi: 10.1053/j.ajkd.2016.06.023
Peralta R, Gamarra Fleitas F, Gómez Fernández MN, Vaesken Rojas J, Frutos López RD, Galeano Vera SM. Características clínicas de la anemia en la enfermedad renal crónica de pacientes del Hospital Nacional en 2018. Rev virtual Soc Parag Med Int. 2019;6(1):11–20. doi: 10.18004/rvspmi/2312-3893/2019.06(01)11-020
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’ Callaghan A, Lasserson DS, et al. Global prevalence of chronic kidney disease – A systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi: 10.1371/journal.pone.0158765.
Fan J, Yan P, Wang Y, Shen B, Ding F, Liu Y. Prevalence and Clinical significance of low T3 syndrome in non-dialysis patients with chronic kidney disease. Med Sci Monit. 2016;22:1171–9. doi: 10.12659/MSM.895953
Ortega Chavarría M, Seniscal Arredondo D, Díaz Greene E, Rodríguez Weber F. Síndrome eutiroideo enfermo. Acta Med Grup Angeles. 2019;17(2):131–6. doi: 10.1177/088506669701200505
Da Costa ABBA, Pellizzari C, Carvalho GA, Sant’Anna BC, Montenegro RL, Zammar Filho RG, et al. High prevalence of subclinical hypothyroidism and nodular thyroid disease in patients on hemodialysis. Hemodial Int. 2016;20(1):31–7. doi: 10.1111/hdi.12339
Cotoi L, Borcan F, Sporea I, Amzar D, Schiller O, Schiller A, et al. Thyroid pathology in end-stage renal disease patients on hemodialysis. Diagnostics. 2020;10(4):245–57. doi: 10.3390/diagnostics10040245
Cuna V, Menghi V, Comai G, Cappuccilli M, Cianciolo G, Raimondi C, et al. Functional abnormalities and thyroid nodules in patients with end-stage renal disease. In Vivo (Brooklyn). 2017;31(6):1203–8. doi: 10.21873/invivo.11191
Huang CW, Li BH, Reynolds K, Jacobsen SJ, Rhee CM, Sim JJ. Association between hypothyroidism and chronic kidney disease observed among an adult population 55 years and older. Med. 2020;99(17):e19569. doi: 10.1097/MD.0000000000019569
Khatiwada S, Rajendra KC, Gautam S, Lamsal M, Baral N. Thyroid dysfunction and dyslipidemia in chronic kidney disease patients. BMC Endocr Disord. 2015;15:65. doi: 10.1186/s12902-015-0063-9
Thanas C, Ziros PG, Chartoumpekis D V, Renaud CO, Sykiotis GP. The Keap1/Nrf2 signaling pathway in the thyroid — 2020 update. Antioxidants (Basel). 2020;9(11):1082. doi: 10.3390/antiox9111082
de Souza ABC, Arantes MF, Zatz R, Elias RM, Lopes RI, Macedo E. Influence of low free thyroxine on progression of chronic kidney disease. BMC Nephrol. 2020;21(1):36. doi: 10.1186/s12882-019-1677-3
Remuzzi G, Perico N. Perspectiva de la Sociedad Internacional de Nefrología con respecto al surgimiento de enfermedades renales crónicas de etiología desconocida o indeterminada. MEDICC Rev. 2014;16(2):75–6. Disponible en: https://www.medigraphic.com/pdfs/medicreview/mrw-2014/mrw142m.pdf
Lee Y, Park S, Lee S, Kim Y, Kang MW, Cho S, et al. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study. PLoS One. 2020;15(4):e0231328. doi: 10.1371/journal.pone.0231328
Ortellado Maidana J, Ramírez A, González G, Olmedo Filizzola G, Ayala de Doll M, Sano M, et al. Consenso Paraguayo de Hipertension Arterial 2015. Rev Virtual Soc Parag Med Int. 2016;3(2):11–57. doi: 10.18004/rvspmi/2312-3893/2016.03(02)11-057
García Salinas HA, Barreto RS, Gavilán Herreros JA, Insfrán Echauri EM, Sisa Ferreira CG, Santa Cruz Segovia FV. Detección de enfermedad renal crónica oculta en personas del Bañado Sur de Asunción. Rev virtual Soc Parag Med Int. 2015;2(1):23–30. doi: 10.18004/rvspmi/2312-3893/2015.02(01)23-030
Frenz P, Titelman D. Equidad en salud en la region más desigual del mundo: un reto de políticas públicas. Rev Peru Med Exp Salud Publica. 2013;30(4):665–70. doi: 10.17843/rpmesp.2013.304.246
Pan B, Du X, Zhang H, Hua X, Wan X, Cao C. Relationships of chronic kidney disease and thyroid dysfunction in non-dialysis patients: A pilot study. Kidney Blood Press Res. 2019;44(2):170–8. doi: 10.1159/000499201